Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001108205-24-000074
Filing Date
2024-12-23
Accepted
2024-12-23 08:38:01
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 cris-sx3resalewarrants.htm S-3 257043
2 EX-FILING FEES curis-dec2024sx3xex107fili.htm EX-FILING FEES 33870
3 EX-5.1 curis-ex51xwhopinion.htm EX-5.1 12109
4 EX-23.1 s-3exhibit231pwcconsent.htm EX-23.1 1937
5 image.jpg GRAPHIC 3363
6 image_0a.jpg GRAPHIC 67372
7 image_3.jpg GRAPHIC 30039
  Complete submission text file 0001108205-24-000074.txt   444860
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-284009 | Film No.: 241570204
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)